Free tool
FAERS Monitor: Tylenol
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019872 or its brand name (Tylenol, Acetaminophen). Reports on generic versions are filed under their own applications.
Reports
268,179
Serious
228,491
85% of reports
Hospitalization
117,898
Death reported
51,202
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use24,108
- fatigue21,605
- drug ineffective20,037
- pain19,054
- nausea18,843
- headache17,716
- toxicity to various agents16,820
- dyspnoea15,471
- vomiting14,962
- arthralgia14,927
- pyrexia14,876
- diarrhoea14,262
- rash13,105
- pneumonia11,656
- infusion related reaction11,382
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2,587 |
| 2005 | 2,683 |
| 2006 | 3,149 |
| 2007 | 2,550 |
| 2008 | 3,851 |
| 2009 | 2,960 |
| 2010 | 3,783 |
| 2011 | 8,051 |
| 2012 | 8,030 |
| 2013 | 3,362 |
| 2014 | 4,020 |
| 2015 | 6,241 |
| 2016 | 8,978 |
| 2017 | 8,260 |
| 2018 | 10,004 |
| 2019 | 13,343 |
| 2020 | 20,343 |
| 2021 | 20,681 |
| 2022 | 27,877 |
| 2023 | 28,724 |
| 2024 | 29,377 |
| 2025 | 29,017 |
| 2026 | 20,297 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,785,980 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| infusion related reactionSignal | 11,382 | 16.0 | 15.7 | 133,465 |
| toxicity to various agentsSignal | 16,820 | 8.6 | 8.4 | 102,188 |
| pyrexiaSignal | 14,876 | 3.5 | 3.4 | 25,557 |
| pneumoniaSignal | 11,656 | 2.9 | 2.8 | 14,120 |
| arthralgiaSignal | 14,927 | 2.9 | 2.8 | 18,057 |
| vomitingSignal | 14,962 | 2.5 | 2.5 | 13,895 |
| painSignal | 19,054 | 2.5 | 2.4 | 16,774 |
| rashSignal | 13,105 | 2.4 | 2.4 | 10,599 |
| headacheSignal | 17,716 | 2.3 | 2.2 | 12,343 |
| fatigueSignal | 21,605 | 2.2 | 2.2 | 14,449 |
| off label useSignal | 24,108 | 2.2 | 2.2 | 15,858 |
| dyspnoeaSignal | 15,471 | 2.2 | 2.1 | 9,822 |
| nausea | 18,843 | 1.9 | 1.9 | 7,987 |
| diarrhoea | 14,262 | 1.7 | 1.7 | 4,618 |
| drug ineffective | 20,037 | 1.2 | 1.2 | 672 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.